Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sarcoma × Decitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 55 Myelodysplastic Syndromes 23 Leukemia 13 Leukemia, Myelomonocytic, Chronic 11 Recurrence 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Congenital Abnormalities 8 Myeloproliferative Disorders 7 Primary Myelofibrosis 5 Thrombocythemia, Essential 4 Polycythemia Vera 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Neoplasms 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Head and Neck Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Burkitt Lymphoma 3 Blast Crisis 3 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Neuroblastoma 2 Myelodysplastic-Myeloproliferative Diseases 2 Mesothelioma, Malignant 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lung Neoplasms 2

Interventions

Doxorubicin 24 Cyclophosphamide 24 Gemcitabine 14 Radiotherapy 12 Filgrastim 11 pazopanib 10 pembrolizumab 9 Cisplatin 9 Docetaxel 8 Radiation 7 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Carboplatin 7 Busulfan 7 fludarabine 6 Trabectedin 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Melphalan 6 Ipilimumab 6 Etoposide 6 Bevacizumab 6 selinexor 5 olaratumab 5 Temozolomide 5 Leucovorin 5 Irinotecan 5 aflibercept 4 Topotecan 4 Thiotepa 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02959164 2023-07-28

Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma

University of Iowa

Phase 1 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡